Home › Graves Disease › California › San Francisco
Graves Disease clinical trials in San Francisco, CA
4 studies for Graves Disease are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
RecruitingPhase 2
- Site 111, San Francisco
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
RecruitingPhase 3
- Silkiss Eye Surgery, San Francisco
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
RecruitingPhase 2
- Site Number - 1034, San Francisco
Evaluating an AI Tool for Detecting Thyrotoxic States
RecruitingObservational study
- Umesh Masharani, San Francisco
Graves Disease trials in other cities
- Houston, TX8 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Asheville, NC5 studies
- San Antonio, TX5 studies
- Hialeah, FL4 studies
- El Paso, TX4 studies
- Washington, DC3 studies
- Havelock, NC3 studies
- Raleigh, NC3 studies
- Farmington Hills, MI3 studies
- Kansas City, MO3 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.